EcoDrugPlus

Ensembl ID : ENSACIG00000018427
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSACIG00000000461
Gene Symbol: -
Cross references: -
237 Possible Orthologues:

Ensembl ID : ENSACIG00000006230
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSACIG00000006159
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSACIG00000006117
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSACIG00000006068
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSACIG00000006699
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSACIG00000006662
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSACIG00000017629
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSACIG00000017611
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSACIG00000007561
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSACIG00000015099
Gene Symbol: -
Cross references: -
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).